The most valuable information in investigating dyspepsia comes from gastroscopic examination.
This has generated expectations that other causes of dyspepsia can be successfully treated in similar ways.
Compared with the previous year, the costs for dyspepsia drugs had declined by approximately 8%.
Between 10% and 20% of patients with more than occasional dyspepsia have ulcers, and approximately 10% have reflux esophagitis, while less than 1% have cancer.
Nevertheless, economic analyses could not include longterm outcome measures unless clinical studies assessing the natural history of functional dyspepsia are performed.
Can the age limit for endoscopy be increased in dyspepsia patients who do not have alarm symptoms?
Days with dyspepsia were measured by multiplying dyspeptic episodes by the duration of episodes.
Symptom relief from functional dyspepsia can be achieved by antacids when the problems have a dominant element of reflux of acid into the esophagus.
